Research has confirmed that the COVID-19 mortality rate sharply increases among seniors, with the majority of deaths reported among those aged 70 years and older 3 , and among individuals who have pre-existing conditions such as frailty, obesity, diabetes and hypertension independent of age 3
Kondo, M., Toyoda, M., Kimura, M., Ishida, N
GLP-1 support patches Easy-to-use topical patch format Made in USA Manufactured in a GMP-compliant facility Clean formulation with quality ingredients Designed for convenient daily use GLP-1 Patches are patches designed for convenient daily use
Semaglutide# Semaglutide has the most extensive GLP-1 evidence base: SUSTAIN (T2D injectable, 7 trials), PIONEER (T2D oral, 9 trials), STEP (obesity, multiple trials), and SELECT (cardiovascular outcomes, n=17,604, 20% MACE reduction)
No Opt-In for Pharmacies Pharmacies do not need to take any steps to opt-in into the Bridge Program
USA 110 , 35073512 (2013)